Home > Newsletters > FDAnews Drug Daily Bulletin > Gilead’s Blockbuster HIV Drug Truvada Gets First-Ever Preventive Indication
FDAnews Drug Daily Bulletin
July 18, 2012 | Vol. 9 No. 140
Gilead’s Blockbuster HIV Drug Truvada Gets First-Ever Preventive Indication
The FDA has green-lighted a new indication for Gilead’s Truvada as the first pill to help prevent HIV infection in high-risk patients. The approval comes with a risk evaluation and mitigation strategy (REMS) to lower the risk of developing drug-resistant HIV-1 variants if HIV-negative patients interrupt their dosing and then contract the virus.
Drug Industry Daily
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.